---
title: Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma
  Following Preoperative FOLFIRINOX
date: '2025-01-23'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39847363/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250124170819&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS AND RELEVANCE: In this cohort study, adjuvant (m)FOLFIRINOX
  and other multiagent chemotherapy regimens were associated with improved OS following
  resection of localized pancreatic adenocarcinoma after preoperative (m)FOLFIRINOX,
  whereas single-agent adjuvant chemotherapy was not. The impact of adjuvant chemotherapy
  on OS may be lower in subgroups such as patients with 8 or more preoperative cycles
  of (m)FOLFIRINOX, those having radiological response, and those with ...'
disable_comments: true
---
CONCLUSIONS AND RELEVANCE: In this cohort study, adjuvant (m)FOLFIRINOX and other multiagent chemotherapy regimens were associated with improved OS following resection of localized pancreatic adenocarcinoma after preoperative (m)FOLFIRINOX, whereas single-agent adjuvant chemotherapy was not. The impact of adjuvant chemotherapy on OS may be lower in subgroups such as patients with 8 or more preoperative cycles of (m)FOLFIRINOX, those having radiological response, and those with ...